Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026)
Nuwellis (NUWE) reported Total Non-Current Liabilities of $3.9 million for Q1 2026, up 31.09% on a YoY basis from $3.0 million in Q1 2025, and up 26.82% quarter-over-quarter from $3.1 million in Q4 2025.
Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
Nuwellis has reported Total Non-Current Liabilities for 11 years, with the latest figure at $3.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 31.09% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 31.09% YoY), and the FY2025 full-year result was $3.1 million, up 8.13% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $3.9 million, up from $3.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $14.5 million in Q2 2025, with the low at $2.9 million in Q4 2024.
- Historically, Total Non-Current Liabilities has averaged $4.6 million across 5 years, with a median of $4.3 million in 2022.
- The largest YoY upside for Total Non-Current Liabilities was 225.27% in 2025 against a maximum downside of 37.68% in 2025.
- Nuwellis' Total Non-Current Liabilities stood at $5.4 million in 2022, then sank by 31.79% to $3.7 million in 2023, then slipped by 22.87% to $2.9 million in 2024, then climbed by 8.13% to $3.1 million in 2025, then advanced by 26.82% to $3.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $3.9 million (Q1 2026), $3.1 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 14.46 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 4.82 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 30, 2022 | 4.42 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 4.29 Mn |
| Sep 30, 2021 | 3.83 Mn |
| Dec 31, 2020 | 3.69 Mn |